Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -19,862 | -11,746 | -5,279 | -23,967 |
| Depreciation Amortization | 476 | 302 | 159 | 619 |
| Other Working Capital | -1,877 | -2,329 | -2,817 | 3,300 |
| Other Operating Activity | 1,163 | 702 | 309 | 1,150 |
| Operating Cash Flow | $-20,100 | $-13,071 | $-7,628 | $-18,898 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -670 | -38 | -33 | -96 |
| Investing Cash Flow | $-670 | $-38 | $-33 | $-96 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 177 | 8 | 6 | N/A |
| Other Financing Activity | 152,934 | 33,240 | 21,309 | 8,610 |
| Financing Cash Flow | $153,111 | $33,248 | $21,315 | $8,610 |
| Beginning Cash Position | 10,526 | 10,526 | 10,526 | 20,910 |
| End Cash Position | 142,867 | 30,665 | 24,180 | 10,526 |
| Net Cash Flow | $132,341 | $20,139 | $13,654 | $-10,384 |
| Free Cash Flow | ||||
| Operating Cash Flow | -20,100 | -13,071 | -7,628 | -18,898 |
| Capital Expenditure | -670 | -38 | -33 | N/A |
| Free Cash Flow | -20,770 | -13,109 | -7,661 | -18,898 |